Evaluating the Cost-effectiveness of Realistic Screening Interventions Across Sev

评估跨部门的现实筛查干预措施的成本效益

• 批准号: 7810575
• 负责人: David B Rein
• 金额: $ 15.06万
• 依托单位: RESEARCH TRIANGLE INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7810575
• 关键词: Accounting; Address; Adult; Age; Age related macular degeneration; Blindness; Caring; Castor; Cataract; Characteristics; Communities; Computer software; Data; Detection; Diabetic Retinopathy; Disease; Effectiveness; Effectiveness of Interventions; Epidemiology; Ethnic Origin; Eye; Eye diseases; Funding; Gender; Health; Health Resources; Health Services; Heterogeneity; Home environment; Impairment; Individual; Insurance Coverage; Intervention; Java; Language; Latino; Lead; Los Angeles; Measures; Medical; Modeling; Natural History; Nuclear; Patients; Pattern; Personal Satisfaction; Population; Population Group; Population Heterogeneity; Primary Open Angle Glaucoma; Race; Recommendation; Recording of previous events; Research; Research Personnel; Screening procedure; Services; Simulate; Social Welfare; Software Tools; Testing; United States; Vision; Vision Disorders; Visual; Visual Fields; age group; age related; base; computerized; cost; cost effectiveness; design; economic cost; health care service utilization; improved; innovation; interest; models and simulation; patient population; prevent; programs; service utilization; user friendly software

DESCRIPTION (provided by applicant): Evaluating the cost-effectiveness of ophthalmologic screening initiatives can guide decisions about when and where to implement screening. If done well, these analyses can help target scarce visual health resources in a way that maximizes societal well-being at a reasonable cost. The need for targeted visual health screening in the United States is increasing as the U.S. population ages because the epidemiology of major adult visual disorders is age-related. However, assessing the cost-effectiveness of visual screening is complicated by subpopulation differences in the routine use of visual screening services. Models that fail to account for this heterogeneity may lead to erroneous conclusions about where and when screening services are justified. In Aim 1 of this project, we will make substantial improvements to an existing visual health simulation model that will enable it to account for heterogeneous patient screening histories based on empirically observed patient data from the Beaver Dam Eye Study and the Los Angeles Latino Eye Study. The model will be unique in at least three important respects: (1) it will be the only cost-effectiveness model that includes the benefits of preventing multiple eye diseases with a single screening intervention; (2) it will be the only visual health screening model that evaluates the cost-effectiveness of a visual health screening intervention implemented in a realistic, mixed-age group population; and (3) it will be the only visual health model that incorporates real patient data at the individual level, which enables the model to simulate the benefit of screening among a mixed group of heterogeneous patients. In Aim 2, we will use the improved model to estimate the cost-effectiveness of visual health screening interventions when considering the benefits of preventing multiple eye diseases and accounting for patient differences in past service use, insurance coverage, and costs to screen. Finally, in Aim 3, we will use the results from our cost-effectiveness analyses to develop a user-friendly software tool that will enable findings to be disseminated to a wide range of decision makers, practitioners, and researchers in a way that is most meaningful in their individual setting. If successful, the project as a whole could lead to improvements in the targeting of visual health screening services and enhancements to the public welfare at a reasonable cost.

描述（由申请人提供）：评估眼科筛查计划的成本效益可以指导有关何时和何时实施筛查的决策。如果做得好，这些分析可以帮助以合理的成本最大化社会福祉的方式针对稀缺的视觉健康资源。随着美国人口年龄的增长，美国对有针对性的视觉健康筛查的需求正在增加，因为主要成人视力障碍的流行病学与年龄相关。但是，评估视觉筛查的成本效益因常规使用视觉筛选服务的亚群差异而变得复杂。未能解释这种异质性的模型可能会导致关于筛查服务合理性的错误结论。在该项目的AIM 1中，我们将根据现有的视觉健康模拟模型做出重大改进，该模型将根据Beaver Dam Eye研究和洛杉矶Latino Latino Eye研究的经验观察到的患者数据来考虑异质的患者筛查历史。该模型在至少三个重要方面将是独一无二的：（1）它将是唯一包括通过单个筛查干预措施预防多重眼部疾病的好处的成本效益模型； （2）这将是唯一评估在现实，混合年龄群体中实施的视觉健康筛查干预措施的成本效益的视觉健康筛查模型； （3）这将是唯一在单个水平上结合实际患者数据的唯一视觉健康模型，这使该模型能够模拟在混合的异质患者中筛查的好处。在AIM 2中，我们将使用改进的模型来估计视觉健康筛查干预措施的成本效益，以预防多种眼部疾病的好处，并考虑到过去的服务使用，保险范围和筛查成本的患者差异。最后，在AIM 3中，我们将使用我们的成本效益分析的结果来开发一种用户友好的软件工具，该工具将以最有意义的方式将调查结果传播到广泛的决策者，从业者和研究人员中。如果成功的话，整个项目可能会改善视觉健康筛查服务的目标，并以合理的成本对公共福利增强。